PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för pitavastatin. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

24 hits

Bibliografisk träff 2012-11-14

Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C.

Kohjima M, Enjoji M, Yoshimoto T, Yada R, Fujino T, Aoyagi Y, Fukushima N, Fukuizumi K, Harada N, Yada M, Kato M, Kotoh K, Nakashima M, Sakamoto N, Tanaka Y, Nakamuta M.

J Med Virol · research support, non-u.s. gov't; journal article · DOI 10.1002/jmv.23464

Bibliografisk träff 2012-09-25

Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans.

Oh ES, Kim CO, Cho SK, Park MS, Chung JY.

Drug Metab Pharmacokinet · research support, non-u.s. gov't; journal article · DOI 10.2133/dmpk.dmpk-12-rg-068

Bibliografisk träff 2012-09-05

The administration of pitavastatin augments creatinine clearance associated with reduction in oxidative stress parameters: acute and early effects.

Kakuda H, Kanasaki K, Koya D, Takekoshi N.

Clin Exp Nephrol · research support, non-u.s. gov't; journal article · DOI 10.1007/s10157-012-0689-0

Bibliografisk träff 2012-08-11

Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: the PREMIUM Study.

Matsubara T, Naruse K, Arakawa T, Nakao M, Yokoi K, Oguri M, Marui N, Amano T, Ichimiya S, Ohashi T, Imai K, Sakai S, Sugiyama S, Ishii H, Murohara T.

J Cardiol · clinical trial; multicenter study; journal article · DOI 10.1016/j.jjcc.2012.07.012

Bibliografisk träff 2012-08-08

Effects of pitavastatin on cardiac structure and function and on prevention of atrial fibrillation in elderly hypertensive patients: a prospective study of 2-years' follow-up.

Warita S, Kawasaki M, Tanaka R, Ono K, Kojima T, Hirose T, Iwama M, Watanabe T, Nishigaki K, Takemura G, Noda T, Watanabe S, Minatoguchi S.

Circ J · journal article · DOI 10.1253/circj.cj-12-0722

Bibliografisk träff 2012-07-31

Effects of grapefruit juice and SLCO1B1 388A>G polymorphism on the pharmacokinetics of pitavastatin.

Hu M, Mak VW, Yin OQ, Chu TT, Tomlinson B.

Drug Metab Pharmacokinet · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.2133/dmpk.dmpk-12-rg-067

Bibliografisk träff 2012-07-01

Comparison of the safety, tolerability, and pharmacokinetic profile of a single oral dose of pitavastatin 4 mg in adult subjects with severe renal impairment not on hemodialysis versus healthy adult subjects.

Morgan RE, Campbell SE, Yu CY, Sponseller CA, Muster HA.

J Cardiovasc Pharmacol · research support, non-u.s. gov't; journal article; clinical trial, phase iv · DOI 10.1097/fjc.0b013e318256cdf0

Bibliografisk träff 2012-06-18

Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients.

Nomura S, Taniura T, Shouzu A, Omoto S, Inami N, Fujita S, Tamaki T, Yokoi T, Shimizu T, Ito T.

Int J Gen Med · research-article; journal article · DOI 10.2147/ijgm.s31346

Bibliografisk träff 2012-06-07

Pitavastatin shows greater lipid-lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia.

Stender S, Budinski D, Gosho M, Hounslow N.

Eur J Prev Cardiol · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1177/2047487312451251

Bibliografisk träff 2012-06-01

Effects of steady-state lopinavir/ritonavir on the pharmacokinetics of pitavastatin in healthy adult volunteers.

Morgan RE, Campbell SE, Suehira K, Sponseller CA, Yu CY, Medlock MM.

J Acquir Immune Defic Syndr · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1097/qai.0b013e318251addb

Bibliografisk träff 2012-04-19

Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase.

Ohira M, Endo K, Saiki A, Miyashita Y, Terai K, Murano T, Watanabe F, Tatsuno I, Shirai K.

Metabolism · research support, non-u.s. gov't; journal article · DOI 10.1016/j.metabol.2012.03.010

Bibliografisk träff 2012-04-01

Pleiotropic effects of pitavastatin.

Davignon J.

Br J Clin Pharmacol · research support, non-u.s. gov't; research-article; review; journal article · DOI 10.1111/j.1365-2125.2011.04139.x

Bibliografisk träff 2012-03-10

Pharmacokinetic interaction between pitavastatin and valsartan: a randomized, open-labeled crossover study in healthy male Korean volunteers.

Jung JA, Noh YH, Jin S, Kim MJ, Kim YH, Jung JA, Lim HS, Bae KS.

Clin Ther · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.clinthera.2012.01.026

Bibliografisk träff 2012-03-01

Pitavastatin: a review of its use in the management of hypercholesterolaemia or mixed dyslipidaemia.

Duggan ST.

Drugs · review; journal article · DOI 10.2165/11207180-000000000-00000

Bibliografisk träff 2012-02-23

Effects of pitavastatin on pressure overload-induced heart failure in mice.

Kameda Y, Hasegawa H, Kubota A, Tadokoro H, Kobayashi Y, Komuro I, Takano H.

Circ J · research support, non-u.s. gov't; journal article · DOI 10.1253/circj.cj-11-1114

Bibliografisk träff 2012-02-15

The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C.

Teramoto T.

Expert Opin Pharmacother · review; journal article · DOI 10.1517/14656566.2012.660525

Bibliografisk träff 2012-02-13

Randomized comparison of pitavastatin and pravastatin treatment on the reduction of urinary albumin in patients with type 2 diabetic nephropathy.

Kimura S, Inoguchi T, Yokomizo H, Maeda Y, Sonoda N, Takayanagi R.

Diabetes Obes Metab · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1463-1326.2012.01566.x

Bibliografisk träff 2012-01-23

Pitavastatin demonstrates long-term efficacy, safety and tolerability in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia.

Stender S, Budinski D, Hounslow N.

Eur J Prev Cardiol · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1177/2047487312437326

Bibliografisk träff 2012-01-09

Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin.

Yu CY, Campbell SE, Zhu B, Knadler MP, Small DS, Sponseller CA, Hunt TL, Morgan RE.

Curr Med Res Opin · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1185/03007995.2011.648264

Bibliografisk träff 2011-12-01

Pitavastatin decreases tau levels via the inactivation of Rho/ROCK.

Hamano T, Yen SH, Gendron T, Ko LW, Kuriyama M.

Neurobiol Aging · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neurobiolaging.2011.10.020

Bibliografisk träff 2011-11-11

Effects of the SLCO1B1*15 allele on the pharmacokinetics of pitavastatin.

Choi CI, Lee YJ, Lee HI, Kim BH, Kim MJ, Jang CG, Bae JW, Lee SY.

Xenobiotica · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.3109/00498254.2011.632030

Bibliografisk träff 2011-05-25

The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins.

Hua WJ, Hua WX, Fang HJ.

Cardiovasc Ther · review; journal article · DOI 10.1111/j.1755-5922.2011.00290.x

Bibliografisk träff 2011-05-18

Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia.

Poolsup N, Suksomboon N, Wongyaowarat K, Rungkanchananon B, Niyomrat P, Kongsuwan S.

J Clin Pharm Ther · meta-analysis; comparative study; review; journal article · DOI 10.1111/j.1365-2710.2011.01274.x

Bibliografisk träff 2010-11-13

Rationale and design of a study to evaluate effects of pitavastatin on Japanese patients with chronic heart failure: the pitavastatin heart failure study (PEARL study).

Mizuma H, Inoue T, Takano H, Shindo S, Oka T, Fujimatsu D, Kuwabara Y, Node K, Komuro I, PEARL Study Investigators.

Int J Cardiol · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.ijcard.2010.10.022